Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2590-2597

  Ancelin, Marie L ^a   Calas, Michèle ^b   Vidal Sailhan, Valérie ^b   Herbuté, Serge ^a   Ringwald, Pascal ^c   Vial, Henri J ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; CHLOROQUINE; E 10; G 25; G 5; HALOFANTRINE; MEFLOQUINE; PHOSPHOLIPID; QUATERNARY AMMONIUM DERIVATIVE; QUININE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ERADICATION THERAPY; ERYTHROCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PARASITE CULTIVATION; PARASITE ISOLATION; PARASITEMIA; PHOSPHOLIPID METABOLISM; PLASMODIUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; CELL SURVIVAL; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MULTIPLE; ERYTHROCYTES; HUMANS; JURKAT CELLS; MACROPHAGES; MEGAKARYOCYTES; PHOSPHOLIPIDS; PLASMODIUM FALCIPARUM; PYRROLIDINES; QUATERNARY AMMONIUM COMPOUNDS;

EID: 0043095590     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2590-2597.2003     Document Type: Article

References (38)

1. Adovelande, J., J. Deleze, and J. Schrevel. 1998. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum. Biochem. Pharmacol. 55:433-440.
2. Ancelin, M. L., M. Calas, J. Bompart, G. Cordina, D. Martin, M. Ben Bari, T. Jei, P. Druilhe, and H. J. Vial. 1998. Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood 91:1426-1437.
3. Ancelin, M. L., M. Parant, M. J. Thuet, J. R. Philippot, and H. J. Vial. 1991. Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection. Biochem. J. 273:701-709.
4. Ancelin, M. L., and H. J. Vial. 1989. Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes. Biochim. Biophys. Acta 1001:82-89.
5. Ancelin, M. L., F. Vialettes, and H. J. Vial. 1991. An original method for rapid serial determination of phospholipid biosynthesis. Applications to mammalian lymphocytic cells and a lower eucaryote, Plasmodium falciparum. Anal. Biochem. 199:203-209.
6. Ancelin, M. L., M. Calas, A. Bonhoure, S. Herbute, and H. J. Vial. 2003. In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism. Antimicrob. Agents Chemother. 47:2598-2605.
7. Breman, J. G., A. Egan, and G. T. Keusch. 2001. The intolerable burden of malaria: a new look at the numbers. Am. J. Trop. Med. Hyg. 64:iv-vii.
8. Calas, M., M. L. Ancelin, G. Cordina, P. Portefaix, G. Piquet, V. Vidal-Sailhan, and H. Vial. 2000. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. J. Med. Chem. 43:505-516.
9. Calas, M., G. Cordina, J. Bompart, M. Ben Bari, T. Jei, M. L. Ancelin, and H. Vial. 1997. Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis. J. Med. Chem. 40:3557-3566.
10. Cheng, Y., and W. H. Prusoff. 1973. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108.
11. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
12. Dieckmann, A., and A. Jung. 1986. Stage-specific sensitivity of Plasmodium falciparum to antifolates. Z. Parasitenkd. 72:591-594.
13. Durand, R., E. Gabbett, J. P. Di Piazza, J. F. Delabre, and J. Le Bras. 1999. Analysis of kappa and omega repeats of the cg2 gene and chloroquine susceptibility in isolates of Plasmodium falciparum from sub-Saharan Africa. Mol. Biochem. Parasitol. 101:185-197.
14. Geary, T. G., A. A. Divo, and J. B. Jensen. 1989. Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. Am. J. Trop. Med. Hyg. 40:240-244.
15. Gumila, C., M. L. Ancelin, G. Jeminet, A. M. Delort, G. Miquel, and H. J. Vial. 1996. Differential in vitro activities of ionophore compounds against Plasmodium falciparum and mammalian cells. Antimicrob. Agents Chemother. 40:602-608.
16. Hastings, I. M., and U. D'Alessandro. 2000. Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitol. Today 16:340-347.
17. Holz, G. G. 1977. Lipids and the malaria parasite. Bull. W. H. O. 55:237-248.
18. Jambou, R., N. A. Ghogomu, D. Kouka-Bemba, and C. Hengy. 1992. Activity of chloroquine and desferrioxamine in vitro against newly isolated Plasmodium falciparum and their antagonism in combination. Trans. R. Soc. Trop. Med. Hyg. 86:11.
19. Jensen, J. B., and W. Trager. 1977. Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle jar method. J. Parasitol. 63:883-886.
20. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
21. Ogura, M., Y. Morishima, R. Ohno, Y. Kato, N. Hirabayashi, H. Nagura, and H. Saito. 1985. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66:1384-1392.
22. Olliaro, P. L., and Y. Yuthavong. 1999. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol. Ther. 81:91-110.
23. Peters, W. 1984. Antimalarial drugs I, vol. 68. Springer-Verlag, Berlin, Germany.
24. Pradines, B., C. Rogier, T. Fusai, A. Tall, J. F. Trape, and J. C. Doury. 1998. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am. J. Trop. Med. Hyg. 58:354-357.
25. Ringwald, P., J. Bickii, and L. K. Basco. 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am. J. Trop. Med. Hyg. 55:254-258.
26. Ringwald, P., F. S. Meche, J. Bickii, and L. K. Basco. 1999. In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera. J. Clin. Microbiol. 37:700-705.
27. Sherman, L. 1979. Biochemistry of Plasmodium (malarial parasites). Microbiol. Rev. 43:453-495.
28. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
29. Van Deenen, L. L. M., and J. De Gier. 1975. Lipids of the red cell membrane, p. 147-211. In G. Surgenor (ed.), The red blood cell. Academic Press, New York, N.Y.
30. Vial, H., and M. Ancelin. 1998. Malarial lipids, p. 159-175. In I. Sherman (ed.), Malaria: parasite biology, pathogenesis, and protection. ASM Press, Washington, D.C.
31. Vial, H. J., and M. L. Ancelin. 1992. Malarial lipids. An overview. Subcell. Biochem. 18:259-306.
32. Vial, H. J., and M. Calas. 2001. Inhibitors of phospholipid metabolism, p. 347-365. In P. Rosenthal (ed.), Antimalarial chemotherapy, mechanisms of action, modes of resistance, and new directions in drug development. Humana Press, Totowa, N.J.
33. Vial, H. J., P. Eldin, D. Martin, L. Gannoun, M. Calas, and M. L. Ancelin. 1999. Transport of phospholipid synthesis precursors and lipid trafficking into malaria-infected erythrocytes. Novartis Found. Symp. 226:74-88.
34. Vial, H. J., M. J. Thuet, and J. R. Philippot. 1982. Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures. J. Protozool. 29:258-263.
35. von Seidlein, L., P. Milligan, M. Pinder, K. Bojang, C. Anyalebechi, R. Gosling, R. Coleman, J. I. Ude, A. Sadiq, M. Duraisingh, D. Warhurst, A. Alloueche, G. Targett, K. McAdam, B. Greenwood, G. Walraven, P. Olliaro, and T. Doherty. 2000. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355:352-357.
36. Wengelnik, K., V. Vidal, M. L. Ancelin, A. M. Cathiard, J. L. Morgat, C. H. Kocken, M. Calas, S. Herrera, A. W. Thomas, and H. J. Vial. 2002. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 295:1311-1314.
37. Winstanley, P. A. 2000. Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. Parasitol. Today 16:146-153.
38. Yeo, H. J., M. P. Larvor, M. L. Ancelin, and H. J. Vial. 1997. Plasmodium falciparum CTP: phosphocholine cytidylyltransferase expressed in Escherichia coli: purification, characterization and lipid regulation. Biochem. J. 324:903-910.